This cost-utility analysis compares the cost-effectiveness of salmeterol, fluticasone propionate, combination salmeterolfluticasone, and no maintenance therapy in chronic obstructive pulmonary disease.
Yuji Oba, MD
Advertisement
Articles by Yuji Oba, MD
Continuous home oxygen therapy for chronic obstructive pulmonary disease seems more cost-effective than other health technologies covered by Medicare, while nocturnal oxygen therapy is not.
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease
Published: February 14th 2009 | Updated:
- Cost-Effectiveness of Salmeterol, Fluticasone, and Combination Therapy for COPD
Published: April 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
3
NICU Nurses More Likely to Miss Tasks Due to Increased Workload
4
Value-Based Care Interventions and Management of CKD Progression
5
